Cargando…
On ceramides, other sphingolipids and impaired glucose homeostasis()
In most people with type 2 diabetes, progression from obesity to diabetes is accompanied by elevated tissue exposures to a variety of lipids. Among these lipid species, ceramides and more complex sphingolipids have gained recent attention as being pathophysiologically relevant for the development of...
Autores principales: | Larsen, Philip J., Tennagels, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986510/ https://www.ncbi.nlm.nih.gov/pubmed/24749054 http://dx.doi.org/10.1016/j.molmet.2014.01.011 |
Ejemplares similares
-
Sphingolipid and Ceramide Homeostasis: Potential Therapeutic Targets
por: Young, Simon A., et al.
Publicado: (2012) -
Circulating Sphingolipids and Glucose Homeostasis: An Update
por: Ali-Berrada, Sarah, et al.
Publicado: (2023) -
Ceramide sensing by human SPT-ORMDL complex for establishing sphingolipid homeostasis
por: Xie, Tian, et al.
Publicado: (2023) -
Apoptotic Sphingolipid Ceramide in Cancer Therapy
por: Huang, Wei-Ching, et al.
Publicado: (2011) -
Sortilin drives hypertension by modulating sphingolipid/ceramide homeostasis and by triggering oxidative stress
por: Varzideh, Fahimeh, et al.
Publicado: (2022)